Arterial stiffness as a model to dissect chronic inflammation in FMF by unknown
POSTER PRESENTATION Open Access
Arterial stiffness as a model to dissect chronic
inflammation in FMF
O Kukuy1,2*, A Leiba2,3,4, L Mendel5, A Benor6, E Giat7, O Perski1, O Feld1, Y Kessel1, I Ben Zvi8, M Lidar7,
A Livneh1,3,7,8
From 8th International Congress of Familial Mediterranean Fever and Systemic Autoinflammatory Diseases
Dresden, Germany. 30 September - 3 October 2015
Background
Familial Mediterranean fever (FMF) is an autoinflamma-
tory disorder, characterized by short attacks of sterile ser-
ositis, successfully suppressed by continuous colchicine
treatment. Subclinical chronic inflammation however, is
a frequent finding in FMF, manifested with elevated
levels of inflammatory markers
(CRP, SAA). While chronic inflammation is considered
an important cardiovascular (CV) risk factor in most
inflammatory disorders, findings on the impact of
chronic inflammation in FMF are conflicting. Chronic
inflammation is an important cause of arterial stiffness,
an early sign and independent risk factor of cardiovascu-
lar atherosclerosis. Pulse wave velocity (PWV) measure-
ment is a useful marker of arterial stiffness.
Objectives
To study arterial stiffness in FMF and evaluate its pre-
disposing factors.
Methods
Eighty consecutive FMF patients without known CV risk
factors, were enrolled to the study, during their sched-
uled visit to the clinic. Demographic, genetic, clinical,
and laboratory data were obtained from their file and
examination. Arterial stiffness was determined through
pulse wave velocity (PWV), measured by Sphygmocor
system algorithm (AtCor Medical, Sydney, Australia).
The recorded PWV values were standardized per age and
blood pressure and coded as PWV_Z, relating to the
reference general population.
Results
Compared with the adjusted general population, FMF
patients displayed normal PWV values, even with a sig-
nificantly reduced dispersion around the mean (5% vs
10%, p=0.02). In a trial to identify pro- or counteracting
driving factors no statistically significant variables were
found, yet the dose of the colchicine demonstrated the
strongest trend for normalizing PWV.
Conclusion
Arterial stiffness is not increased in FMF. Our data sup-
port a role for colchicine prophylaxis in this finding.
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